Amy Thornton Palatiello advises clients on reimbursement and product commercialization for medical devices, diagnostics, and pharmaceuticals with a focus on the impact of regulatory and legislative changes related to Medicare payment policy.

In particular, Amy has extensive experience in Medicare coverage policy, end-stage renal disease payment issues, and durable medical equipment competitive bidding policy.

Prior to Avalere, Amy was a healthcare policy analyst for the Washington Research Group, where she informed institutional investors from the nation's largest mutual, hedge, and retirement funds about how Washington legislation and regulations would impact publicly traded healthcare companies. Amy also worked for the Centers for Medicare & Medicaid Services as a health policy specialist focusing on Part D implementation and waste, fraud, and abuse policy.

Amy has an MPH in health policy and administration from the University of Minnesota and a BA from the University of Wisconsin.

Authored Content

Avalere experts hosted a lively discussion on the 2019 outlook for the medical device industry.